Medifast, Inc. (MED) Return on equity 2016–2025
Medifast, Inc. (MED) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-9.6%FY2025 · since FY2016: 18.6% → -9.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -9.6% | -10.5 pp |
| FY2024 | 1.0% | -48.2 pp |
| FY2023 | 49.1% | -43.7 pp |
| FY2022 | 92.9% | +11.9 pp |
| FY2021 | 81.0% | +15.6 pp |
| FY2020 | 65.4% | -8.9 pp |
| FY2019 | 74.3% | +23.2 pp |
| FY2018 | 51.1% | +25.1 pp |
| FY2017 | 26.0% | +7.4 pp |
| FY2016 | 18.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice